Wecare Probiotics Co., Ltd. – Trademark Portfolio

Entity Type: 99

Wecare Probiotics Co., Ltd. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 3 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 3 Nice Classification classes. Currently, 0 trademarks are registered and 2 are pending. The owner is based in Suzhou, Jiangsu.

No.1033 Longqiao Road, Wujiang

Suzhou, Jiangsu 215299 , CN

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

BC99
BC99
Pending 2026
BC99
BC99
Pending 2026
WECCUL
WECCUL
Abandoned 2023

Trademark Classifications

Wecare Probiotics Co., Ltd.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (3 filings)

Advertising; business management; business administration; office functions

1
Chemicals (2 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Wecare Probiotics Co., Ltd. have?

Wecare Probiotics Co., Ltd. has 3 U.S. trademarks filed with the USPTO. Of these, 2 pending, 1 abandoned.

What trademark classes does Wecare Probiotics Co., Ltd. file in?

Wecare Probiotics Co., Ltd. files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 1 (Chemicals), Class 5 (Pharmaceuticals). Class 35 covers advertising; business management; business administration; office functions.

What is Wecare Probiotics Co., Ltd.'s trademark registration success rate?

Wecare Probiotics Co., Ltd. has a 0% trademark registration rate, with 0 out of 1 resolved applications resulting in successful registration. Currently, 2 applications are pending review.